Symbiotec Pharmalab makes tepid market debut, lists at par with IPO price

As reported by Share Market Today

The listing of Symbiotec Pharmalab was well below GMP expectations, which had indicated a listing gain of around 18-19 per cent for IPO investors.

▸ MARKET SAMACHAR VIEW

NEUTRAL

Read full article on Share Market Today ↗

Market Samachar is a news aggregator. This article was originally published by Share Market Today. Tap the button above to read the full story on their site.

INDIAN Bajaj Auto rallies 3%, trades near record high; tops share buyback price Share Market Today
COMPANIES Ace investor Ashish Dhawan picks up 35 lakh shares in Religare Enterprises; stock jumps 5% Stocks-Markets-Economic Times
INDIAN Fed Chair Warsh sees global investment surge replacing savings glut Markets-Economic Times
INDIAN Why your first Rs 25 lakh investment is a major wealth-creation milestone Markets-Economic Times
INDIAN Global Market: Japan bond yields hit 3% for first time in 30 years amid inflation, fiscal risks Markets-Economic Times
INDIAN Global Market: Yen weakness puts BOJ under pressure for faster monetary tightening Markets-Economic Times
INDIAN Bitcoin holds near $79K as traders avoid aggressive profit booking. Here's what experts say Markets-Economic Times
INDIAN Auto-parts maker Victura Technologies said to weigh India IPO Markets-Economic Times

Symbiotec Pharmalab makes tepid market debut, lists at par with IPO price

More from Market Samachar